Ajou University repository

Cancer immunology research
ISSN
  • E2326-6074
  • P2326-6066
Publisher

American Association for Cancer Research Inc.

Listed on
(Coverage)

JCR2014-2023

SJR2014-2020;2022-2023

CiteScore2013-2023

SCIE2014-2024

SCOPUS2017-2024

MEDLINE2016-2024

EMBASE2016-2024

Active
Active

based on the information

  • SCOPUS:2024-10
Country
USA
Aime & Scopes
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.
Article List

Showing results 1 to 1 of 1

A neuropilin-1 antagonist exerts antitumor immunity by inhibiting the suppressive function of intratumoral regulatory T cellsoa mark
  • Jung, Keunok;
  • Kim, Jeong Ah;
  • Kim, Ye Jin;
  • Lee, Hyun Woo;
  • Kim, Chul Ho;
  • Haam, Seokjin;
  • Kim, Yong Sung
  • 2020-01-01
  • Cancer Immunology Research, Vol.8 No.1, pp.46-56
  • American Association for Cancer Research Inc.
1